Rating: Neutral | Target Price: RMB 285–405 (base-case fair value range, midpoint RMB 345) | Current Price: RMB 393 (close as of 2026-09-01) | Margin of Safety: approx. -27% (current price is above the base-case fair value floor of RMB 285, no margin of safety) | Time Horizon: 6–9 months | Report Date: 2026-09-02
| Item | Previous (2026-05-01) | Current (2026-09-02) | Reason for Change |
|---|---|---|---|
| Rating | Cautiously Bullish | Neutral | Cycle has shifted from "accelerating upswing" into "top zone": spot price momentum faded in August, NAND contract prices judged to have peaked at historical highs, and the company issued a voluntary risk warning; the stock's 53% pullback from RMB 840 has largely priced in H1 results, probability-weighted fair value (approx. RMB 355) is below the current price, and risk/reward has weakened |
| Confidence | 0.60 | 0.55 | Gap between current price and fair value has narrowed to about 10%, but uncertainty over the timing of the cycle inflection (4Q26–2027) remains high |
| Target Price Range | No structured range set (text used PE 60x ≈ RMB 180 as reference anchor) | RMB 285–405 | First time anchoring on three scenarios: 2027E net profit attributable of RMB 8.8–10.2 bn × 22–27x exit multiple (a compromise anchored on the median of IDM peers and the premium of A-share fabless platforms; not using the company's current market multiple) |
| Valuation Judgment | Argument level: "valuation already overextended" (C5) | Overvalued (mild) | TTM PE compressed from approx. 100x to 34.9x, but this is a "peak-trough low PE": normalized PE remains as high as 79–126x |
| Verification of Previous Arguments | — | — | C1 supercycle: materialized (H1 revenue +178.7%) and has entered the top zone; C2 earnings quality: maintained and reinforced (net cash RMB 17.35 bn); C3 customized storage volume production in 2026: pushed back (annual report wording → "expected to enter volume production in H2"); C4 insider selling/lock-up expiry/FX/inventory: insider selling completed, cashing out approx. RMB 4.4 bn, lock-up expiry passed, buybacks and share increases providing offset; C5 high valuation: maintained |
Earnings realized at the cycle top, current price already pricing in peak continuation—Neutral while waiting for a pullback. 2026H1 revenue was RMB 11.566 bn (+178.7%), non-GAAP (recurring) net profit RMB 4.883 bn (+796.9%); the earnings explosion of the memory supercycle has materialized in the financials. However, in August the DRAM spot average price rose only +0.67% MoM, NAND contract prices were judged by TrendForce to have peaked at historical highs, and in late June the company voluntarily announced a warning that prices "will see a considerable pullback"—the steepest phase of the rally is most likely over. The current price of RMB 393 corresponds to a TTM PE of 34.9x, a classic "peak-trough low PE"; on a normalized basis PE is 79–126x. The probability-weighted fair value across three scenarios is approx. RMB 355, -9.8% vs. the current price; the odds structure (bear -59% / bull +54%) does not support adding to positions. Only the announcement event flow for September–December (Q3 report, contract prices, share-increase window) remains somewhat bullish; hence Neutral rather than bearish: holders may stay invested with the RMB 405 upper bound / RMB 285 lower bound as discipline boundaries, while new capital should wait for a pullback or falsification of the cycle inflection.
2026H1 revenue was RMB 11.566 bn (+178.7%), recurring net profit RMB 4.883 bn (+796.9%); Q2 standalone revenue was RMB 7.378 bn and net profit attributable RMB 5.396 bn (including fair value gains); memory gross margin was 67.6% (H1 basis, approx. 66.6% in Q2). TrendForce's official guidance: 3Q26 server DRAM contract prices +13–18% QoQ (long-term contracts capped), NAND +10–15%; NOR/SLC NAND expected to rise another 60–65% in 2H26; in early September media cited TrendForce raising PC DRAM price gains to 18–23% (secondhand citation, to be verified). Full-year net profit attributable is estimated at RMB 11.0–13.0 bn (implying H2 of RMB 4.1–6.1 bn; since the CXMT stake is held at FVOCI and does not flow through P&L, and H2 non-recurring items shrink markedly, full-year elasticity mainly depends on recurring profit of RMB 10.0–11.0 bn).
Contract prices hitting new highs are a lagging confirmation signal (contracts lag spot by 1–2 quarters); "flat spot prices + contract catch-up" is the typical price-spread structure of a late-cycle phase — C1 and C2 should be read together.
August DRAM spot average price was USD 42.90, up only +0.67% MoM with subdued trading; TrendForce judged in June that NAND contract prices had peaked at historical highs; Morgan Stanley in early July proposed an industry "peak rate of change" (share of earnings upgrades fell from a 92% peak to 77%, expecting 4Q26 contract price gains to peak)—note that its original text also forecasts memory earnings still growing 35–40% in 2027, i.e., a "flattening slope" rather than an "outright decline," and its late-August view holds that CXMT/YMTC will fill the supply gap in 2026–27, with supply-demand impact only after 2028. The hardest evidence comes from the company: the 2026-06-30 risk warning announcement explicitly stated "product prices are already at historical highs… as niche memory market capacity increases at the margin, prices will see a considerable pullback." Memory accounted for 85% of H1 revenue with a 67.6% gross margin; based on estimated 2026E memory revenue of approx. RMB 22.8 bn, every 10% decline in ASP (volume and cost unchanged) erodes gross profit by approx. RMB 2.3 bn, or 18% of 2026E EBITDA (approx. RMB 12.7 bn).
Net cash at end-2026H1 was approx. RMB 17.35 bn (cash RMB 16.965 bn + trading financial assets RMB 0.472 bn − interest-bearing debt RMB 0.085 bn, zero bank borrowings), with H1 free cash flow of RMB 5.10 bn — but net cash is only approx. 6.3% of market cap, and DRAM fundraising projects and capacity expansion will gradually consume it. Shareholder behavior has turned from net outflow to net inflow: the RMB 1.0–2.0 bn cancellation buyback had executed RMB 654 mn as of 8/31 (at RMB 375–412); the controlling shareholder's ≥RMB 1.0 bn share-increase window opens 2026-12-13, with a 12-month no-sale commitment. However, the buyback cap is only 0.72% of market cap, and the combined buyback + share-increase cap of approx. RMB 3.0 bn is still smaller than the approx. RMB 4.4 bn cashed out by the controlling shareholder's May–June sell-down. The holding of 1.086 bn CXMT shares is worth approx. RMB 61.3 bn at the current price of approx. RMB 56–57 (book value RMB 10.062 bn at end-H1); revaluation through other comprehensive income starting with the Q3 report would add approx. RMB 73 per share to book value (total stake value approx. RMB 87 per share) — but this stake is FVOCI (gains never flow through P&L; disposal only transfers to retained earnings), and CXMT has been listed for less than two months with high price volatility—paper wealth, not a usable buffer.
Of H1 net profit attributable of RMB 6.857 bn, non-recurring items were RMB 1.974 bn (28.8%), including RMB 2.228 bn of fair value gains on securities investments (32.5% of net profit attributable)—reversible and market-dependent. FX losses of RMB 418 mn (vs. a gain of RMB 15 mn in the prior-year period) were a volatility item reducing profit, not a cosmetic item. R&D capitalization ratio rose to 20.8% (FY2024: 10.65%), but the impact on profit is approx. RMB 100 mn, about 2% of recurring profit—a noise-level blemish. What truly needs monitoring is inventory: book balance of RMB 4.467 bn (+32.7% vs. start of year), with the impairment provision ratio down to 6.33% (14.74% end-2023 → 13.71% end-2024 → 8.89% end-2025, four consecutive years of decline)—under-provisioning boosts profit in the upcycle, and the NRV revaluation impairment elasticity will be magnified equally when the cycle reverses. Recurring profit of RMB 4.883 bn is the true operating profit (H1 recurring net margin 42.2%).
RMB 393 corresponds to a market cap of approx. RMB 276.7 bn (simplified basis: A-share price × total A+H share capital of approx. 704 mn shares), TTM PE of 34.9x (19th percentile of the past 5 years)—TTM net profit attributable of RMB 7.93 bn is a historical peak including approx. RMB 1.97 bn of non-recurring items; the low percentile is an illusion of peak earnings. PB of 7.42x is at the 71st percentile of the past 5 years. Normalized net profit of RMB 2.2–3.5 bn (center approx. RMB 2.8 bn, EPS approx. RMB 4.0) corresponds to a normalized PE of 79–126x at the current price; the current price ≈ 25.9x FY2027E consensus (net profit approx. RMB 10.7 bn, about 3.8x the normalized center). On microstructure: 48 ratings with zero sells, consensus revised up 193% over the past 90 days, mean target price of RMB 417.15 only +6.1% above the current price—in a crowded trade structure, the damage from any consensus downgrade is amplified. EPV (zero growth) is approx. RMB 60 per share (operating normalized EPS RMB 3.55 / WACC 10% / net cash per share RMB 24.65); approx. 85% of the current price rests on "continuation of cycle windfall + growth options" (this proportion is not unique among A-share digital chip designers, noted for structural context only). Base-case fair value is RMB 285–405; the current price is near the upper end of the range.
Directional evidence is ample: SPI NOR content per AI server rises from 2–4 chips in traditional servers to 18–24 in 8-GPU systems and hundreds per rack (industry estimates); the company says it is being continuously designed into compute cards/gateway/PCIe switch applications; Qingyun's customized storage is being sampled across AI phones/AI PCs/automotive cockpits/robots, with the company stating "some projects are expected to enter volume production in H2"; LPDDR4X volume production is progressing and MCU prices have risen moderately since Q2. But auditability is insufficient: the company's share in AI server NOR has no public data, and the conversion chain from content multiples to revenue elasticity breaks at the first link; Qingyun's volume production timing has slipped versus the 2025 annual report wording ("2026 volume production" → "expected in H2"), and from first volume production to revenue ramp typically takes 12–18 months; the MCU price-increase source is partly sell-side judgment rather than company price letters. The bull case's (normalized center lifting to RMB 4.5–6.0 bn) 25% probability is a subjective judgment; the verification point is whether the Q3 report breaks out customized storage revenue and server-grade NOR share.
| Metric | FY2023 | FY2024 | FY2025 | 2026H1 (latest) |
|---|---|---|---|---|
| Revenue (RMB bn) | 5.761 | 7.356 | 9.203 | 11.566 (+178.7%) |
| Net profit attributable (RMB bn) | 0.161 | 1.103 | 1.648 | 6.857 (+1091.5%) |
| Recurring net profit (RMB bn) | 0.027 | 1.030 | 1.469 | 4.883 (+796.9%) |
| Gross margin | 34.42% | 38.00% | 40.21% | 63.13% (memory 67.57%) |
| Net margin attributable | 2.8% | 15.0% | 17.9% | 59.3% (recurring basis 42.2%) |
| Operating cash flow (RMB bn) | 1.187 | 2.032 | 2.129 | 6.048 |
| Free cash flow (RMB bn) | — | 1.532 | 1.080 | 5.103 |
| Cash (RMB bn) | — | — | 9.186 | 16.965 |
| Interest-bearing debt (RMB bn) | — | — | 0.297 | 0.085 (zero bank borrowings) |
| Debt-to-asset ratio | — | — | 10.2% | 11.5% |
| Inventory book balance (RMB bn) | 2.335 | 2.719 | 3.365 | 4.467 (provision ratio 6.33%) |
| Contract liabilities (RMB bn) | — | — | 0.218 | 0.452 (+107.3% vs. start of year) |
Reasons for metric changes (accounts with YoY ≥ ±20%, company disclosure basis): Revenue +178.67%—memory chip supply tightness, volume and price both up (memory +245.44%, MCU +49.07%); gross margin jump—revenue growth far outpaced cost growth (COGS up only +63.63%); net profit attributable +1091.5%—beyond operating leverage, includes RMB 2.228 bn fair value gains on securities investments; financial expenses swung from -RMB 147 mn to +RMB 224 mn—increase in FX losses of RMB 418 mn; OCF +531.47%—net inflow from sales collections and procurement payments increased by approx. RMB 5.54 bn; inventory balance +32.7%—increased memory stockpiling purchases (accounts payable up +102.9% in tandem to RMB 1.649 bn, offsetting supply-chain financing); CapEx +129.1%—increased DRAM R&D equipment investment; accounts receivable +126.19%—expanding with revenue, receivables/revenue only 3.8%, collections still strong.
Q2 standalone revenue was RMB 7.378 billion (up 76.1% QoQ), net profit attributable to shareholders RMB 5.396 billion (up 269.2% QoQ), with a standalone net margin of 73.1% (including fair value gains; ex-non-recurring H1 net margin of 42.2%). Driver breakdown: volume and price gains in niche DRAM and SLC NAND were the main engine (a supply vacuum left by overseas majors shifting capacity to HBM/DDR5 and EOL-ing legacy products), NOR prices rose modestly, and MCU began seeing mild price hikes in Q2; wafer/packaging & testing cost inflation was fully absorbed by price increases. Results were broadly in line with the positive earnings pre-announcement (net profit ~RMB 6.9 billion / revenue ~RMB 11.5 billion)—a case of "pre-announced and delivered." Market reaction was a sell-the-news pullback: the day after the interim report, A-shares fell 1.64% and H-shares fell 6.6%—with TTM PE elevated and the market focused on the quality of fair value gains and the sustainability of price hikes, the beat itself carried no incremental information. Versus sell-side estimates: consensus FY2026E net profit of ~RMB 7.7 billion clearly lags the H1 actuals (upward revisions of 193% within 90 days post-earnings; FY2026E EPS raised from RMB 8.67 to RMB 10.97), and the denominator will jump again after Q3 results; judging "whether the market has priced it in" should be anchored to FY2027E (~RMB 10.7 billion)—at the current price of 25.9x FY2027E, consensus expectations are already nearly fully priced.
Business model: Fabless chip design platform—memory (NOR + SLC NAND + niche DRAM, 85% of H1 revenue) + MCU (12.4%) + sensors/analog; revenue has no subscription/recurring attributes and is typical cyclical hardware sales, but current pricing power is extremely strong due to supply shortage (H1 ex-non-recurring net margin of 42.2% is a historical extreme, which the company itself expects to give back as the cycle turns). Remaining performance obligations of RMB 9.794 billion (of which RMB 9.415 billion to be recognized within 2026) provide near-term revenue visibility.
Cash content of earnings: OCF/net profit went from 1.85 in 2024 → 1.27 in 2025 → 0.88 in 2026H1 (1.24 on an ex-non-recurring basis; the decline is mainly due to RMB 2.228 billion of non-cash fair value gains included in net profit—after excluding them, cash conversion remains healthy); FCF/net profit went from 1.39 in 2024 → 0.64 in 2025 → 0.74 in 2026H1. Receivables/revenue is only 3.8%, and inventory growth is partially offset by payables (+102.9%)—profit-to-cash conversion is genuine, with no red flags of receivables buildup on an ex-non-recurring basis.
Recurring earnings test (key): The gap between H1 attributable net profit of RMB 6.857 billion and ex-non-recurring RMB 4.883 billion is 28.8% (≥15% threshold): ~RMB 2.23 billion comes from fair value gains on securities investments (mark-to-market, reversible), while RMB 418 million of FX losses suppressed results in the opposite direction—this company's earnings must be assessed on an ex-non-recurring basis: true operating earnings for 2026H1 were RMB 4.883 billion, annualizing to ~RMB 9.8 billion.
Return on capital: FY2025 ROIC ~8.7% (NOPAT/invested capital), annualizing to ~18% in 2026H1—up-cycle equity returns surge, but across the cycle ROIC fell below 3% in 2023; ROIC volatility far exceeds the "steady 15%+" of a moat-type business. Net cash of RMB 17.35 billion depresses the current ROIC calculation (denominator bloat).
Maintenance CapEx scrutiny: CapEx/depreciation went from 1.07 in FY2024 → 2.09 in FY2025 → 3.64 in 2026H1—pro-cyclical equipment investment is clearly accelerating (DRAM R&D equipment, tape-outs). Under a Fabless model this is not a "textile-mill-style" maintenance black hole (CapEx is expansionary R&D investment, not capacity maintenance), but the H1 CapEx growth of +129% implies the FCF/net profit midpoint of 0.64–0.74 has shifted down systematically from 2024's 1.39.
Moat & red flags: Moat = binding to CXMT capacity (RMB 5.7 billion lock-in agreement) + platform of 20,000 customers + automotive certifications (cumulative automotive Flash shipments of 450 million units); red flags = strong cyclical earnings leverage (net margin from 2.8% → 59.3% in just three years) + earnings contain large reversible non-recurring items + cost dependence on a single affiliated foundry (top-five suppliers account for 69.49% of purchases, of which CXMT is 16.38%).
Track record of words vs. deeds: partially delivered, leaning pragmatic. ① Suzhou Saixin profit compensation exceeded targets in both 2024 and 2025 (110.51%/108.31%)—delivered; ② the 2026-07-10 positive earnings pre-announcement closely matched actuals—delivered; ③ DRAM fundraising project progress went from 36.22% at end-2025 to 54.27% at end-2026H1 (H1 investment of RMB 510 million exceeded all of 2025), with multiple DDR3/DDR4 projects in mass production—delivered and accelerating; ④ customized memory mass production timeline pushed back: the 2025 annual report operating plan said "achieve mass-production contribution revenue in 2026" → the 2026 interim report revised to "some projects expected to reach mass production in H2"—partially delivered, timeline deferred, requiring continued follow-up.
Shareholder friendliness: neutral-to-friendly (with flaws). Payout ratio went from 20.5% in FY2024 → 31.9% in FY2025; dividends + buyback-and-cancellation over the past three years totaled RMB 955 million, or 98% of average annual net profit; in August 2026, another RMB 1–2 billion cancellation-style buyback was announced (cap of RMB 750/share). The flaw: controller Zhu Yiming sold 11.11 million shares at highs in May–June, cashing out ~RMB 4.4 billion (in the RMB 339–539 range), and only then, in late July, committed to no further sales + proposed a buyback + intended to increase holdings by ≥RMB 1 billion—a "extract first, support later" one-two punch, with the support ceiling (~RMB 3 billion) smaller than the amount extracted; the H-share share award scheme allows newly issued H-shares to be granted at zero consideration (including wafer/packaging & testing "service providers," i.e., foundry ecosystem partners can become grantees), a governance controversy involving dilution and related-party benefit transfers.
Risk signals: Zhu Yiming also chairs CXMT, the company's largest affiliated supplier (H1 purchases of RMB 1.986 billion, exceeding all of FY2025)—related-party dependence and conflict of interest coexist; the 12-month no-sale commitment expires 2027-07-30, potentially coinciding with a cyclical downturn window; company secretary/joint company secretary change in August 2026; domestic auditor switched to KPMG Huazhen in 2025, and in July 2026 the overseas auditor resigned due to the unification of Chinese Accounting Standards (procedural arrangement, with no standards discrepancies in historical A/H disclosures).
| Segment | Revenue share (2026H1) | Gross margin | YoY | Business logic in one line |
|---|---|---|---|---|
| Memory (NOR+SLC NAND+niche DRAM) | 85.0% (FY2025 71.3%) | 67.57% (FY2025 42.84%) | +245.44% | Supply-gap dividend from majors' exit from niche markets; volume and price both up |
| MCU | 12.4% | 38.49% (FY2025 35.82%) | +49.07% | Largest downstream is industrial; volume-driven with mild price uptrend since Q2 |
| Analog products | 1.6% | 40.50% | High base persists (Suzhou Saixin consolidation) | Power management/motor drivers, cross-sold with MCU |
| Sensors | 0.9% | 19.60% | YoY decline | Fingerprint/touch dragged by smartphone market, intensifying competition |
Profit driver: Memory—85.0% of revenue × 67.57% gross margin contributed ~RMB 6.64 billion of gross profit (91% of total company gross profit); MCU contributed ~RMB 550 million. Gross margin structural gap of 48.0 percentage points (67.57% vs 19.60%): memory is riding an industry-wide supply gap (Winbond/Macronix Q2 gross margins of 64–66% corroborate), while sensors are a fully competitive red ocean—the former is cyclical beta, the latter is the reference for normal competitive dynamics; understanding this is understanding the "temporary" nature of the company's current P&L.
Accounting red flags (pattern / severity / evidence):
Cross-period consistency: ① Inventory balance rose from RMB 2.335 billion → RMB 4.467 billion (+91%) alongside the provision ratio's consecutive declines—the company's explanation of "increased stockpiling" is consistent, but no separate explanation was given for the declining provision ratio; ② Finance costs went from -RMB 443 million → -RMB 142 million → +RMB 224 million, shifting from interest income-driven to FX loss-driven—consistent with management's explanation; ③ OCF/net profit declining from 1.85 → 1.27 → 0.88—not explained by the company; the gap is mainly due to non-cash fair value gains (this report has adjusted to 1.24 on an ex-non-recurring basis); ④ Rising R&D capitalization rate—explanation consistent with footnotes.
Current market data (2026-09-01 close): Share price RMB 393, market cap ~RMB 276.7 billion (simplified calc: A-share price × total A+H share capital of ~704 million shares; H-shares at HKD 475.4 ≈ RMB 407.7, a 3.7% premium to A-shares—foreign investors more optimistic). PE(TTM) 34.89x—0th percentile over 1 year / 0% over 3 years / 19% over 5 years; earnings are unrepresentative—percentiles are reference only: TTM attributable net profit of RMB 7.93 billion is a historical peak (including RMB 1.97 billion non-recurring); 34.9x is a "peak-trough PE" illusion and must not be taken as a cheap signal. PB 7.42x (71st percentile over 5 years; net assets passively inflated by H-share fundraising and CXMT revaluation, passively depressing the percentile); PS(TTM) 16.65x. Forward: 23.1x FY2026E (this report's forecast of RMB 12 billion), 25.9x FY2027E consensus (RMB 10.7 billion); PEG of 0.68 is distorted by cycle-driven supernormal growth and not relied upon.
| Peer | PE(TTM) | PB | 2026H1 earnings elasticity | Note |
|---|---|---|---|---|
| GigaDevice | 34.9 | 7.42 | Revenue +178.7% | Original supplier of commodity chips (design + brand), highest position in the value chain |
| Ingenic | 50.6 | 5.1 | Attributable profit +489.6% | Automotive niche DRAM, high barriers but slightly lower elasticity |
| Puya Semiconductor | 59.6 | 17.73 | Attributable profit +1930% | Small-capacity NOR, narrow product range, high volatility |
| Longsys | 13.2 | 8.54 | Attributable profit 26x+ | Module maker; low PE precisely because the market least believes in its sustainability |
| Winbond | 19.4 | 4.8 (93rd 5-year percentile) | Revenue +184.7% | Global No.1 in NOR; IDM elasticity already priced in |
| Macronix | 29.0 | 3.92 (90th 5-year percentile) | 2025 loss → 2026 windfall | Extreme portrait of cyclicality |
The industry-wide collective "peak-trough PE" (Winbond 19x, Longsys 13x TTM) confirms this is pricing at the top of cyclical earnings rather than individual alpha.
Market-implied expectations: Back-solving from the current price—at a normal 25–30x multiple, RMB 393 implies "sustainable normalized net profit" of RMB 9.2–11.1 billion, almost exactly equal to FY2027E consensus of RMB 10.7 billion. In one sentence: the current price requires 2026–2027's supernormal profits to largely persist as the new normal, whereas true cross-cycle earnings power (normalized net profit of RMB 2.2–3.5 billion) is only a quarter to a third of that. The expectation is not fantasy—the permanent exit of majors from DDR4/2D NAND gives the supply gap a structural component, and rising AI edge-device content could lift the normalized midpoint to RMB 4.5–6.0 billion (bull case)—but paying 25.9x for "peak persistence" offers poor odds.
Three-layer value (EPV): Asset value (floor): book value per share of RMB 53.3 (PB=1x; ~RMB 124 if revalued at CXMT's market price, but CXMT's own pricing is volatile—reference only); EPV with zero growth ~RMB 60/share (operating normalized EPS of RMB 3.55 ÷ WACC 10% + net cash per share of RMB 24.65); growth option = current price − EPV ≈ RMB 333/share (~85%). The current price is almost entirely supported by the "cyclical windfall persistence + growth option" layer—for a cyclical stock this is the norm, not necessarily overvaluation; whether to pay is answered by the scenario distribution. But an 85% share means that once a price inflection is confirmed, the downward correction space is likewise measured in "hundreds of yuan."
Three scenarios & odds (exit multiple anchor: a compromise between IDM peer cycle medians (Winbond 5-year median PE 15.2x / Macronix 7.2x) and A-share design platform premium (SW digital chip design median 52.6x), taken at 22–27x; the company's current multiple not used):
| Scenario | Probability | Fair value range | Implied 2027E | vs. current price | Key drivers |
|---|---|---|---|---|---|
| Bear | 30% | RMB 120–200 (midpoint 160) | Net profit RMB 5.0–6.5bn × 18–22x | -59% (midpoint) / -69% (low end) | Contract prices peak in 4Q26 then fall sharply in 2027: CXMT capacity回流 + majors reallocating + demand destruction; gross margin falls below 45% |
| Base | 45% | RMB 285–405 (midpoint 345) | Net profit RMB 8.8–10.2bn × 22–27x | -12% (midpoint) | Price hikes persist to 2027H1, decline 10–20% in H2; gross margin 55–60% |
| Bull | 25% | RMB 510–700 (midpoint 605) | Net profit RMB 12.0–14.0bn × 30–35x | +54% (midpoint) / +78% (high end) | AI edge + customized memory hand-off; shortage extends to 2028, normalized midpoint lifts to RMB 4.5–6.0bn |
Probability-weighted fair value ~RMB 354.5, -9.8% vs. current price; base-case midpoint -12.2% vs. current—the price sits near the upper edge of the base-case range, odds skewed downward, distribution left-tailed. The bear-case range covers the market's most pessimistic published target (moomoo aggregate low of RMB 183.95) and Morgan Stanley's sector-compression scenario under "peak rate of change"; the bull-case high covers BOCOM International's RMB 687, approaching Nomura's RMB 730. The base-case valuation sits between the market's most bearish and most bullish bids—within bounds.
Own earnings forecast (earnings reconciliation anchor): FY2026 revenue RMB 28.0 billion (26.5–29.5), attributable net profit RMB 12.0 billion (11.5–13.0, ex-non-recurring 10.0–11.0); FY2027 revenue RMB 32.0 billion (30.0–34.5), attributable net profit RMB 9.5 billion (8.5–11.0)—the base path is ~10% below street FY2027E of RMB 10.7 billion. Reference: no quantitative guidance from management (qualitative: supply tightness persists, customized products mass production in H2); consensus FY2026E of RMB 7.7 billion will be revised up, FY2027E RMB 10.7 billion.
Conclusion: mildly overvalued—assess quality and price separately. Quality is strong (net cash of RMB 17.35 billion, H1 FCF of RMB 5.1 billion, platform positioning + domestic substitution), but the price is expensive on cycle position—the current price values peak earnings as the new normal. Target price RMB 285–405 (= base-case fair value), safety margin ~-27% (none). The announcement/event flow over the next 9–12 months leans bullish (Q3 earnings elasticity, monthly contract price data, December share-increase window); bears have only high-frequency spot data to rely on—a "wait" strategy risks being left behind; this is the core reason this report is Neutral rather than Bearish.
1. Industry Size: GigaDevice operates in the "niche memory + general-purpose MCU" track — distinct from the HBM/DDR5/3D NAND commodity markets dominated by the Big Three original manufacturers in pricing bands, yet sharing wafer capacity. According to Frost & Sullivan (cited in the company's 2025 annual report): the global niche memory market in 2025 is approximately USD 15.7 billion (niche DRAM 9.9 billion + NOR 3.1 billion + SLC NAND 2.7 billion), and the global MCU market is approximately USD 21 billion. Macro anchor: WSTS forecasts the global semiconductor market at USD 772 billion in 2025 (+22%), with memory growing 28% as the main growth engine. Growth forecasts: NOR long-term CAGR of roughly 6-7%, MCU roughly 10% (aggregator-based estimates, for cross-reference only, to be verified); there is no long-term CAGR consensus for niche DRAM — it is inherently cyclical, and after prices reach highs in 2026, institutions already expect converging gains in 2027. Quantified demand inflection chain (AI repricing): SPI NOR content per AI server rises from 2-4 units in traditional servers → 18-24 units in 8-GPU systems → hundreds per GB200-class rack (a roughly 6-60x increase); AI server DRAM capacity is 8x that of ordinary servers (indirectly creating niche shortages by siphoning capacity); AI smartphone/PC memory rises from 8-16GB to 16-32GB. However, there is no public data for the "GigaDevice share × shipments within the above increments" step (AI server NOR is currently ~80% monopolized by Winbond, with GigaDevice starting from zero on design-ins), and this inflection has already been largely realized in 2026H1 results — this report treats the company under a cyclical framework and does not switch to a growth-stock valuation anchor.
2. Industry Chain and Value Distribution: Wafer fabrication (CXMT/SMIC/Hua Hong) → design (GigaDevice, fabless) → packaging & testing (JCET/Tongfu/Huatian, outsourced) → OEMs (TV/networking/automotive Tier 1/smartphone/server). Gross margin in this cycle stays at the design layer (GigaDevice 67.6% vs. module maker Longsys in the single-digit to low-double-digit range), but fabless has no in-house capacity elasticity: it captures volume and price upside, while on the downside it is constrained both by foundry prices and capacity quotas; bargaining power over downstream customers will be given back as the cycle reverses. The company has locked in CXMT DRAM wafers at RMB 5.7 billion/year, making it the only design company in China to lock in large-scale DRAM foundry quotas.
3. Supply-Demand and Competitive Landscape: On the demand side, AI servers, edge AI, and automotive electronics pull in three directions, but the company itself admits high prices have suppressed total niche downstream demand; on the supply side, the Big Three's HBM wafer allocation grows by more than +80% in 2025-2026 while traditional DRAM capacity increases by less than 10%; DDR4 EOL direction is set (some lines have delayed closure due to price surges); the 2D NAND-to-3D conversion leaves a gap; CXMT monthly capacity reaches 300k wafers by end-2025 (10-12% global DRAM share), with the Shanghai site planned for 400-600k wafers/month long-term — the marginal increase in niche supply from 2027 onward is the biggest bearish variable of this cycle. Concentration: NOR is an oligopoly of three (formal 2021 CR3 ~91%: Winbond 34.8% + Macronix + GigaDevice; as of July 2026, Taiwanese media estimates Winbond 25-30% / Macronix 20-25% / GigaDevice 15-25% — both figures are presented side by side, the latter being market estimates); after the Big Three original manufacturers exited 95%+ of niche DRAM, capacity has been taken up by CXMT/Nanya/Winbond/GigaDevice; global MCU CR5 >80% (Infineon/NXP/ST/Renesas/Microchip), with GigaDevice holding ~1.3% global share and ranking first among Chinese domestic players. Competitive discipline is sound: the NOR oligopoly did not engage in destructive price cuts even during the 2021-2024 downturn; the main risk is price competition after 2027 as part of CXMT capacity flows back into niche DRAM.
4. Cycle and Regulation: Cycle timing judgment is deferred to the dedicated cycle chapter below. Policy: the Big Fund Phase III (RMB 344 billion) allocates roughly 70% to domestic substitution in equipment and materials; US restrictions on sub-18nm DRAM equipment (CXMT evading via 18.5nm) raise foundry costs; Xinchang (IT innovation) and automotive chip localization are the main battlegrounds for NOR/MCU/niche DRAM domestic substitution — policy is broadly favorable, but the faster CXMT expands, the greater the risk of niche DRAM oversupply after 2027, a negative for GigaDevice's long-term DRAM gross margin.
5. Company Positioning: Top two globally in NOR revenue (Omdia 2025Q1 basis; share figures diverge — Frost & Sullivan 18.5% (cited in the company's annual report) vs. Taiwanese media estimates of 15-25%, with the 2021 CR3 framework as the formal reference); leading in SLC NAND in mainland China; rapidly ramping niche DRAM (2025H1 share ~1.7%, to be verified); first among Chinese domestic MCU players. Share trends: NOR steady to rising, niche DRAM and MCU domestic shares rising. Platform-based resilience to volatility was validated at the tail of the last downturn (2025 revenue +25% / net profit +49%, vs. Puya's net profit -29% in the same period).
1. Cycle Positioning: Template of the last three memory cycles — 2016-2019 (upturn ~2 years: DDR4 iteration + smartphones, cumulative DRAM price gains over 100%; downturn ~1.5 years); 2020-2023 (upturn ~1.5 years: pandemic shortage; downturn ~2 years: cumulative declines over 50%, Macronix loss-making in 2023, niche makers' gross margins falling to ~15%); 2023H2 to present (commodity memory rebounded first, niche lagging 4-6 quarters and exploding in 2025H2: DDR4 spot +172% in 2025, another 80-90% gain in 2026Q1). Pattern: typical cycle 3-4 years, upturn 2-2.5 years. Current core indicators are at historical extremes: DDR4 8Gb spot at ~USD 44.5, about 5.2x the previous 2017 peak (~USD 8.5) and up more than 20x from the 2023 trough — "distance from last peak" is no longer meaningful (far exceeded); niche DDR3 per-GB price has rarely surpassed DDR5; the company itself states NOR prices are "at historical highs." The mechanism-specific nature of this upcycle (AI capex + original manufacturers' conversion discipline) has led some institutions to discuss a "deformed cycle shape," but the company itself still guards against it as a strong cycle — we respect the company's stance.
2. Supply Response (the answer to when the peak comes): Original manufacturers' 2027 capacity is already sold out (DRAM and HBM), niche capacity keeps exiting — tight balance holds within 2026; but from 2027, expansion on CXMT's 300k wafers/month base plus reallocation of the Big Three's EOL legacy capacity forms the timing window for supply to overshoot demand (base case 2027H1-H2). Leading indicators verifiable monthly: spot month-over-month (converged to +0.67% in August), original manufacturers' inventory weeks (extremely low), automotive lead times (>58 weeks), Taiwanese makers' monthly revenue (Winbond +291.6% in August alone — a late-stage high characteristic).
3. Through-Cycle Earnings: Normalized (mid-cycle) net profit of RMB 2.2-3.5 billion (center ~2.8 billion, EPS ~RMB 4.0) — volume based on post-structural-ramp 2026 center revenue of RMB 12-16 billion (full DDR4 lineup + LPDDR4X + SLC NAND + customization foundation), price based on memory gross margin reverting to the 38-45% historical center; trough EPS ~RMB 0.5-1.1 (center ~0.8; next cycle bottom: revenue ~12 billion × net margin 4-5%). The current 34.9x TTM PE is a classic "peak-low PE"; a normalized PE of 25x ±5x (20-30x) corresponds to a price range of RMB 80-119 (25x center ~RMB 100) — a -70% to -80% gap from the current price; even using the upward-shifted center after AI edge realization (RMB 4.5 billion) × 30x yields only RMB 192 (-51%). Asset value floor: book value per share RMB 53.3 (including CXMT marked-to-market, ~RMB 124) — the huge gap between normalized valuation and the current price measures "the premium the market pays for peak-earnings persistence," and is why this report does not assign a higher fair value.
4. Downside Stress Test: With 2026E as the base point (memory revenue ~RMB 22.8 billion, memory gross profit ~RMB 15.4 billion, EBITDA ~RMB 12.7 billion): ASP -10% → EBITDA ~-18%; -20% → -36%; -30% → -54. Three 2027 trough scenarios (R&D rigid at RMB 4 billion/year, 15% tax rate, including inventory writedowns): price -40% / volume -10% → net profit ~RMB 2.38 billion (EPS 3.4); price -50% / volume -15% → ~RMB 890 million (EPS 1.3); price -60% / volume -20% → loss of ~RMB 570 million. No liquidity concern: trough two-year EBITDA remains cumulatively positive and net cash of RMB 17.35 billion barely shrinks; two-year cash consumption (CapEx + buybacks at maximum) ~RMB 4-6 billion, with no refinancing need — the shock hits market value, not the balance sheet; cycle reversal is "a P&L problem, not a survival problem."
5. Management Cycle Discipline: Mixed — at the 2024 cycle bottom, CapEx was only RMB 499 million yet the company injected RMB 1.5 billion into CXMT (now worth tens of billions at fair value — a model of counter-cyclical equity investment) and expanded MCU share at price troughs (a plus); during the 2025-2026 upturn, CapEx stepped up to RMB 945 million in half a year and inventory +91% procyclical stockpiling (neutral); shareholder returns realized in sync with the high (RMB 1-2 billion cancellation-style buybacks + payout ratio 20.5% → 31.9%; the cost-effectiveness of buybacks executed precisely at highs is questionable — if prices fall back in 2027, today's buyback prices of RMB 375-412 will prove to have been the peak).
Rating: Neutral, confidence 0.55, horizon 6-9 months. GigaDevice is one of the biggest beneficiaries of this niche memory cycle: quality (net cash RMB 17.35 billion, annualized non-GAAP profit ~RMB 9.8 billion, platformization + CXMT positioning) is impeccable, but price discipline takes precedence over quality — at RMB 393, the stock already prices "peak-earnings persistence" at 25.9x FY2027E consensus; probability-weighted fair value is RMB 354.5 (-9.8%), with a left-skewed odds distribution (bear -59% / bull +54%). Implications: holders should use RMB 405 (upper bound, valuation realization) and RMB 285 (lower bound, base-case failure and de-rating) as discipline boundaries; new capital should not chase, but wait for one of two signals — price falling near RMB 285, or a cycle inflection being falsified (contract prices staying strong + customized memory materializing), which would raise the bull-scenario probability. To be candid: the announcement flow over the next 9-12 months skews bullish (Q3 earnings elasticity, December share-buying window), so the wait-and-see strategy carries the risk of missing out — hence this report is Neutral rather than Bearish; if Q3 memory gross margin challenges 68-70% and NOR/SLC NAND deliver 60-65% catch-up gains in 2H26, the scenario distribution will shift right.
Risk and Catalyst Summary (in writing): ① Downside — memory contract prices peak in 4Q26 then fall deeply in 2027 (bear scenario -59%): watch TrendForce monthly spot/contract MoM; two consecutive negative months confirm the turn; CXMT's share price decline impacting net assets (holding ~RMB 61.3 billion, listed less than two months); reversal writedowns on inventory of RMB 4.467 billion with a 6.33% provision ratio; consensus downgrade damage in crowded positioning (48 ratings, zero sells, +193% upward revisions over 90 days). ② Upside — Q3 volume-price elasticity and CXMT OCI revaluation (+RMB 73/share of net assets); customized memory mass production in H2 and AI server NOR design-in ramp; share-buying/buyback execution exceeding expectations. ③ Governance monitoring — H-share incentive plan's zero-consideration grant terms; the no-sale commitment expiring 2027-07-30.
(Financial data in this report are as of the 2026 semi-annual report (disclosed 2026-08-19); market data as of the close of 2026-09-01; all valuation estimates are based on this report's own framework; normalized earnings and scenario probabilities are research judgments, for internal reference only.)